Burden of Influenza-Related Hospitalizations Among Children With Sickle Cell Disease

OBJECTIVE: Children with sickle cell disease (SCD) are considered to be at high risk for complications from influenza infection despite minimal published data that characterize the burden of influenza in this population. Our objectives were to (1) estimate the rate of influenza-related hospitalizations (IRHs) among children with SCD, (2) compare this rate with rates of children with cystic fibrosis (CF) and children with neither SCD nor CF, and (3) explore mechanisms that underlie these potentially preventable hospitalizations. METHODS: We analyzed hospitalizations from 4 states (California, Florida, Maryland, and New York) across 2 influenza seasons (2003–2004 and 2004–2005) from the Healthcare Cost and Utilization Project State Inpatient Databases. We included hospitalizations with a discharge diagnosis code for influenza in a child <18 years of age. We used census data and disease prevalence estimates to calculate denominators and compare rates of IRH among children with SCD, CF, and neither disease. RESULTS: There were 7896 pediatric IRHs during the 2 influenza seasons. Of these, 159 (2.0%) included a co-occurring diagnosis of SCD. Annual rates of IRHs were 112 and 2.0 per 10 000 children with and without SCD, respectively, across both seasons. Children with SCD were hospitalized with influenza at 56 times (95% confidence interval: 48–65) the rate of children without SCD. Children with SCD had approximately double the risk of IRH compared with children with CF (risk ratio: 2.1 [95% confidence interval: 1.5–2.9]). IRHs among children with SCD were not longer, more costly, or more severe than IRHs among children without SCD; they were also rarely nosocomial and co-occurred with a diagnosis of asthma in 14% of cases. CONCLUSIONS: IRHs are substantially more common among children with SCD than among those without the disease, which supports the potential importance of vigorous influenza vaccination efforts that target children with SCD.

[1]  T. Jefferson,et al.  Vaccines for preventing influenza in healthy children. , 2012, The Cochrane database of systematic reviews.

[2]  Mandy A. Allison,et al.  High influenza vaccination coverage in children with high-risk conditions during a vaccine shortage. , 2009, Archives of pediatrics & adolescent medicine.

[3]  C. Morris.  Asthma management: Reinventing the wheel in sickle cell disease , 2009, American journal of hematology.

[4]  S. Grosse,et al.  Models of Comprehensive Multidisciplinary Care for Individuals in the United States With Genetic Disorders , 2009, Pediatrics.

[5]  R. Smyth,et al.  Vaccines for preventing influenza in people with cystic fibrosis. , 2009, The Cochrane database of systematic reviews.

[6]  C. Byington,et al.  Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2008–2009 , 2008, Pediatrics.

[7]  C. Bridges,et al.  Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Children 6 to 59 Months of Age During the 2003–2004 and 2004–2005 Influenza Seasons , 2008, Pediatrics.

[8]  R. Hornung,et al.  Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. , 2008, Archives of pediatrics & adolescent medicine.

[9]  Jason B. Caboot,et al.  Pulmonary complications of sickle cell disease in children , 2008, Current opinion in pediatrics.

[10]  K. Poehling,et al.  Influenza Burden for Children With Asthma , 2008, Pediatrics.

[11]  Mari M Nakamura,et al.  Influenza Vaccination in Adolescents With High-Risk Conditions , 2007, Pediatrics.

[12]  Influenza activity--United States and worldwide, 2007-08 season. , 2008, MMWR. Morbidity and mortality weekly report.

[13]  A. Hoes,et al.  Influenza- and respiratory syncytial virus-associated mortality and hospitalisations , 2007, European Respiratory Journal.

[14]  R. Hahn,et al.  Effects on violence of laws and policies facilitating the transfer of youth from the juvenile to the adult justice system: a report on recommendations of the Task Force on Community Preventive Services. , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[15]  R. Baltimore,et al.  Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2006–2007 , 2007, Pediatrics.

[16]  H. Lawson,et al.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[17]  C. Bridges,et al.  Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003–2004 , 2007, Pediatrics.

[18]  W. Schaffner,et al.  Estimating the undetected burden of influenza hospitalizations in children , 2006, Epidemiology and Infection.

[19]  C. Byington,et al.  Epidemiology, Complications, and Cost of Hospitalization in Children With Laboratory-Confirmed Influenza Infection , 2006, Pediatrics.

[20]  Susan E. Coffin,et al.  ICD-9 Codes for Identifying Influenza Hospitalizations in Children , 2006, Emerging infectious diseases.

[21]  C. Bridges,et al.  The underrecognized burden of influenza in young children. , 2006, The New England journal of medicine.

[22]  B. Zuckerman,et al.  Sickle Cell Disease: A Question of Equity and Quality , 2006, Pediatrics.

[23]  C. Glaser,et al.  Severe Pediatric Influenza in California, 2003–2005: Implications for Immunization Recommendations , 2006, Pediatrics.

[24]  W. Schaffner,et al.  Estimating Influenza Hospitalizations among Children , 2006, Emerging infectious diseases.

[25]  J. Gerberding,et al.  Childhood influenza vaccination coverage--United States, 2004-05 influenza season. , 2006, MMWR. Morbidity and mortality weekly report.

[26]  Keiji Fukuda,et al.  Influenza-associated deaths among children in the United States, 2003-2004. , 2005, The New England journal of medicine.

[27]  R. Keren,et al.  Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. , 2005, JAMA.

[28]  P. Szilagyi,et al.  Patient reminder and recall systems to improve immunization rates , 2005 .

[29]  M. Kolczak,et al.  Effectiveness of the 2003–2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 Doses , 2005, Pediatrics.

[30]  A. Greenough,et al.  Asthma in children with sickle cell disease and its association with acute chest syndrome , 2005, Thorax.

[31]  Peter Szilagyi,et al.  Patient reminder and patient recall systems to improve immunization rates. , 2005, The Cochrane database of systematic reviews.

[32]  L. Brammer,et al.  Update: Influenza activity--United States and worldwide, 2004-05 season. , 2005, MMWR. Morbidity and mortality weekly report.

[33]  M. Rosenfeld,et al.  Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. , 2004, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[34]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[35]  Benjamin Schwartz,et al.  Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. , 2004, Pediatrics.

[36]  T. Lieu,et al.  Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. , 2004, Pediatrics.

[37]  J. Gerberding,et al.  Morbidity and Mortality Weekly Report Inside: Continuing Education Examination Applying Public Health Strategies to Primary Immunodeficiency Diseases a Potential Approach to Genetic Disorders Centers for Disease Control and Prevention Epidemiology Program Office Recommendations and Reports 1 Applyin , 2022 .

[38]  Acip.  Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2004 .

[39]  Jennifer Barrow,et al.  Identification and recall of children with chronic medical conditions for influenza vaccination. , 2004, Pediatrics.

[40]  J. Gerberding,et al.  Update: influenza activity--United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. , 2004, MMWR. Morbidity and mortality weekly report.

[41]  M. Drancourt,et al.  Nosocomial influenza in children. , 2003, The Journal of hospital infection.

[42]  T. Koepsell,et al.  Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. , 2003, JAMA.

[43]  Section on Hematology.  Health supervision for children with sickle cell disease. , 2002, Pediatrics.

[44]  Malbea A Lapete,et al.  Morbidity and Mortality Weekly Report Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (acip) Centers for Disease Control and Prevention Epidemiology Program Office Early Release 1 Prevention and Control of Influenza Recommendations of the Advis , 2022 .

[45]  K. Neuzil,et al.  The burden of influenza illness in children with asthma and other chronic medical conditions. , 2000, The Journal of pediatrics.

[46]  Illinois.,et al.  Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs , 2000, Pediatrics.

[47]  P. V. Ichinsky,et al.  Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease , 2000 .

[48]  E F Mitchel,et al.  The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. , 2000, The New England journal of medicine.

[49]  R. Davis,et al.  Influenza and the rates of hospitalization for respiratory disease among infants and young children. , 2000, The New England journal of medicine.

[50]  E. Vichinsky,et al.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. , 2000, The New England journal of medicine.

[51]  T. Jefferson,et al.  Vaccines for preventing influenza in people with asthma. , 2000, The Cochrane database of systematic reviews.

[52]  P. Lane.  Sickle cell disease. , 1996, Pediatric clinics of North America.

[53]  F. Lorey,et al.  Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state , 1996, Genetic epidemiology.

[54]  R. Miller,et al.  Why diagnose influenza infections in hospitalized pediatric patients? , 1993, The Pediatric infectious disease journal.

[55]  M. Thobaben,et al.  Prevention and Control of Influenza , 2003, MMWR. Morbidity and mortality weekly report.

[56]  W. P. Glezen,et al.  Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. , 1983, American journal of diseases of children.

[57]  J. Cherry,et al.  Serologic and clinical response of children with sickle cell disease to bivalent influenza A split virus vaccine. , 1978, The Journal of pediatrics.

[58]  Recommendation of the Public Health Service Advisory Committee on Immunization Practices. , 1969, American journal of diseases of children.